FDA approves med for severe malaria
May 28, 2020
IV artesunate is the only drug available in the U.S. to treat the disease.
All Content
Metformin recalls expected due to carcinogenic ingredient
May 28, 2020
Months after FDA said it was investigating the carcinogenic ingredient N-Nitrosodimethylamine (NDMA) in metformin products, the agency’s testing has found elevated levels of NDMA in extended release (ER) metformin but not in the immediate release (IR) formulation.
Pharma maker recalls drug over undeclared anti-hypertensive drug
May 19, 2020
MasterPharm is voluntarily recalling 1 lot of Finasteride Plus 1.25 mg. capsules to the consumer level.
Top 3 COVID-19 stories this week
May 19, 2020
FDA authorizes first stand-alone, at-home test, plus other top COVID-19 news stories.
FDA clears new antigen, saliva tests for COVID-19
May 11, 2020
Antigen tests, a new category, have a major advantage and disadvantage over COVID-19 tests already approved.
FDA: Fraudulent COVID-19 medical products abound
May 11, 2020
Numerous PPEs and testing kits also feature unproven coronavirus claims.
New subcutaneous multiple myeloma treatment available
May 5, 2020
Formulation could cause fewer administration-related reactions than IV Darzalex.
COVID-19 vaccines could be ready this year, plus other top news
May 5, 2020
Popular heartburn medication now in shortage due to COVID-19 test.
FDA restricts hydroxychloroquine use, plus other COVID-19 updates
April 27, 2020
Agency says the anti-malaria drug can cause heart rhythm problems.
FDA warns CBD companies making medical claims
April 27, 2020
Suppliers claim CBD can help alleviate opioid addiction, cure diseases.
